BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is a comorbidity of childhood obesity. OBJECTIVE: We examined whole-body substrate metabolism and metabolic characteristics in obese adolescents with vs. without NAFLD. SUBJECTS: Twelve obese (BMI ≥ 95th percentile) adolescents with and without NAFLD [intrahepatic triglyceride (IHTG) ≥5.0% vs. <5.0%] were pair-matched for race, gender, age and % body fat. METHODS: Insulin sensitivity (IS) was assessed by a 3-h hyperinsulinemic-euglycemic clamp and whole-body substrate oxidation by indirect calorimetry during fasting and insulin-stimulated conditions. RESULTS: Adolescents with NAFLD had increased (p < 0.05) abdominal fat, lipids, and liver enzymes compared with those without NAFLD. Fasting glucose concentration was not different between groups, but fasting insulin concentration was higher (p < 0.05) in the NAFLD group compared with those without. Fasting hepatic glucose production and hepatic IS did not differ (p > 0.1) between groups. Adolescents with NAFLD had higher (p < 0.05) fasting glucose oxidation and a tendency for lower fat oxidation. Adolescents with NAFLD had lower (p < 0.05) insulin-stimulated glucose disposal and lower peripheral IS compared with those without NAFLD. Although respiratory quotient (RQ) increased significantly from fasting to insulin-stimulated conditions in both groups (main effect, p < 0.001), the increase in RQ was lower in adolescents with NAFLD vs. those without (interaction, p = 0.037). CONCLUSION: NAFLD in obese adolescents is associated with adverse cardiometabolic profile, peripheral insulin resistance and metabolic inflexibility.
BACKGROUND:Non-alcoholic fatty liver disease (NAFLD) is a comorbidity of childhood obesity. OBJECTIVE: We examined whole-body substrate metabolism and metabolic characteristics in obese adolescents with vs. without NAFLD. SUBJECTS: Twelve obese (BMI ≥ 95th percentile) adolescents with and without NAFLD [intrahepatic triglyceride (IHTG) ≥5.0% vs. <5.0%] were pair-matched for race, gender, age and % body fat. METHODS:Insulin sensitivity (IS) was assessed by a 3-h hyperinsulinemic-euglycemic clamp and whole-body substrate oxidation by indirect calorimetry during fasting and insulin-stimulated conditions. RESULTS: Adolescents with NAFLD had increased (p < 0.05) abdominal fat, lipids, and liver enzymes compared with those without NAFLD. Fasting glucose concentration was not different between groups, but fasting insulin concentration was higher (p < 0.05) in the NAFLD group compared with those without. Fasting hepatic glucose production and hepatic IS did not differ (p > 0.1) between groups. Adolescents with NAFLD had higher (p < 0.05) fasting glucose oxidation and a tendency for lower fat oxidation. Adolescents with NAFLD had lower (p < 0.05) insulin-stimulated glucose disposal and lower peripheral IS compared with those without NAFLD. Although respiratory quotient (RQ) increased significantly from fasting to insulin-stimulated conditions in both groups (main effect, p < 0.001), the increase in RQ was lower in adolescents with NAFLD vs. those without (interaction, p = 0.037). CONCLUSION: NAFLD in obese adolescents is associated with adverse cardiometabolic profile, peripheral insulin resistance and metabolic inflexibility.
Authors: Sarah M Lindbäck; Charles Gabbert; Benjamin L Johnson; Emmanuil Smorodinsky; Claude B Sirlin; Natalie Garcia; Perrie E Pardee; Kristin D Kistler; Jeffrey B Schwimmer Journal: Adv Pediatr Date: 2010
Authors: Kitt Falk Petersen; Sylvie Dufour; David B Savage; Stefan Bilz; Gina Solomon; Shin Yonemitsu; Gary W Cline; Douglas Befroy; Laura Zemany; Barbara B Kahn; Xenophon Papademetris; Douglas L Rothman; Gerald I Shulman Journal: Proc Natl Acad Sci U S A Date: 2007-07-18 Impact factor: 11.205
Authors: Brian Bennett; D Enette Larson-Meyer; Eric Ravussin; Julia Volaufova; Arlette Soros; William T Cefalu; Stuart Chalew; Stewart Gordon; Steven R Smith; Bradley R Newcomer; Michael Goran; Melinda Sothern Journal: Obesity (Silver Spring) Date: 2011-08-25 Impact factor: 5.002
Authors: SoJung Lee; Anthony R Deldin; David White; YoonMyung Kim; Ingrid Libman; Michelle Rivera-Vega; Jennifer L Kuk; Sandra Sandoval; Chris Boesch; Silva Arslanian Journal: Am J Physiol Endocrinol Metab Date: 2013-09-17 Impact factor: 4.310
Authors: Anna Kotronen; Anneli Seppälä-Lindroos; Satu Vehkavaara; Robert Bergholm; Keith N Frayn; Barbara A Fielding; Hannele Yki-Järvinen Journal: Liver Int Date: 2009-07-07 Impact factor: 5.828
Authors: Sheela Deivanayagam; B Selma Mohammed; Bernadette E Vitola; Gihan H Naguib; Tamir H Keshen; Erik P Kirk; Samuel Klein Journal: Am J Clin Nutr Date: 2008-08 Impact factor: 7.045
Authors: Fida Bacha; Anca Tomsa; Sara K Bartz; Sarah E Barlow; Zili David Chu; Ramkumar Krishnamurthy; Rajesh Krishnamurthy; E O'Brian Smith Journal: J Endocr Soc Date: 2017-06-27
Authors: Ana Isabel Álvarez-Mercado; Carlos Rojano-Alfonso; Marc Micó-Carnero; Albert Caballeria-Casals; Carmen Peralta; Araní Casillas-Ramírez Journal: Front Cell Dev Biol Date: 2021-06-01